Amanda Pong
Neurology with Special Qualifications in Child Neurology · Stamford, CTNPI 1750583399
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,816 of the $9,602 with a category attached, or 81.4%. It is spread thinly across 37 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,944 and has fallen 63.0% since, to $1,458 in 2025.
Across 293 payments — averaging $32.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- H. Lundbeck A S$2K
- Livanova USA, Inc.$862
- SK Life Science, Inc.$636
- Neurelis, Inc.$474
- Jazz Pharmaceuticals Inc.$402
- plus $4K from 31 others
Across 25 payments — averaging $9048.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$226K
What the payments were for
- Travel & lodging$1,76918%
- Food & beverage$7,81681%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 50 | $1,981 |
| H. Lundbeck A S | 3 | $1,511 |
| Livanova USA, Inc. | 11 | $862 |
| SK Life Science, Inc. | 31 | $636 |
| Neurelis, Inc. | 26 | $474 |
| Jazz Pharmaceuticals Inc. | 11 | $402 |
| Sunovion Pharmaceuticals Inc. | 18 | $297 |
| Kyowa Kirin, Inc. | 13 | $278 |
| Sumitomo Pharma America, Inc. | 20 | $262 |
| Argenx US, Inc. | 11 | $261 |
| Biocodex, Inc. | 7 | $246 |
| Eisai Inc. | 12 | $212 |
| Lilly USA, LLC | 9 | $202 |
| Immedica Pharma US, Inc. | 6 | $186 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| Inspire Medical Systems, Inc. | 1 | $137 |
| Genentech USA, Inc. | 5 | $136 |
| Banner Life Sciences, LLC | 5 | $134 |
| Biomarin Pharmaceutical Inc. | 2 | $133 |
| Catalyst Pharmaceuticals, Inc. | 6 | $130 |
| Biogen | 5 | $124 |
| Aquestive Therapeutics, Inc. | 5 | $104 |
| Harmony Biosciences LLC | 3 | $103 |
| Upsher-smith Laboratories LLC | 5 | $95 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $76 |
| Aucta Pharmaceuticals, Inc. | 4 | $75 |
| Pyros Pharmaceuticals, Inc. | 1 | $74 |
| Neurocrine Biosciences, Inc. | 2 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Sanofi | 2 | $47 |
| Acadia Pharmaceuticals Inc | 1 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Neuropace, Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| AbbVie | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,602 in reported general payments places this provider in the 70th percentile of 28 neurology with special qualifications in child neurology providers in Connecticut.
See all neurology with special qualifications in child neurology providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 15 | $2,719 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Stamford
- Jong RhoNew Haven$55K
- Susan LevyGuilford$38K
- Francine TestaGuilford$38K
- Alok BhargavaFarmington$27K
- William YornsDanbury$19K
- Azimuddin KaziStratford$16K
- Cristian IonitaHartford$15K
- Jennifer Madan CohenHartford$10K
- Lauren Beslow KayeNew Haven$5K
- David MandelbaumNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.